Arsanis Biosciences Gmbh

Janssen Pharmaceuticals, Inc.

Max-planck-gesellschaft Zur F&#xf6;rderung Der Wissenschaften E. V.

X4 Pharmaceuticals (austria) Gmbh

X4 Pharmaceuticals, Inc.

Adriana Badarau

Eszter Nagy

Irina Mirkina

Gábor Nagy

Jolanta Lukasiewicz

Zoltán Magyarics

Bianka Prinz

Laura M Walker

Valéria Szijárto

Gerhild Zauner

Luis Guachalla

Zóltan Magyarics

Luis Gauchalla

Astrid Teubenbacher

Manuel Zerbs

Zehra Visram

Valeria Szijárto

Tushar S Jain

Michaela Jaegerhofer

Ivana Dolezilkova

Michael Benjamin Battles

Katharina Ramoni

Gäbor Nagy

Tim Rollenske

Hedda Wardemann

Harald Rouha

Lukas Stulik

Nels Nielson

Valeria Szijarto

Jolanta Katarzyna Lukasiewicz

Bianka Dominique Prinz

Gabor Nagy

Zoltan Magyarics

The subject relates to an isolated antibody that specifically binds to O25b antigen of multi drug resistant (MDR)strains, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated epitope recognized the specific antibody.

MDRimmunogen

MDRspecific antibody

A cross-neutralizing monoclonal antibody that specifically recognizes a cross-reactive epitope of the lipopolysaccharide (LPS) antigen structure of, which is an O3b epitope, cross-reacting with an O3a epitope and an O3 epitope, wherein the antibody is characterized by specific CDR sequences or VH and VL sequences.

O3 specific antibodies

[object Object]

The subject relates to a cross-neutralizing antibody comprising at least one polyspecific binding site that binds to alpha-toxin (Hla) and at least one of the bi-component toxins of, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated conformational epitope recognized by a specific cross-neutralizing antibody.

Growing community of inventors

Vienna, Austria

Adriana Badarau